chr16-1204375-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 1P and 18B. PP3BP4_ModerateBP6_Very_StrongBS1BS2
The NM_021098.3(CACNA1H):c.2368G>A(p.Val790Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000132 in 1,567,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000075 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 missense
NM_021098.3 missense
Scores
9
8
2
Clinical Significance
Conservation
PhyloP100: 7.83
Publications
7 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
PP3
Multiple lines of computational evidence support a deleterious effect 7: BayesDel_noAF, Cadd, M_CAP, MutationAssessor, phyloP100way_vertebrate, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.13133818).
BP6
Variant 16-1204375-G-A is Benign according to our data. Variant chr16-1204375-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 585634.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000663 (101/152344) while in subpopulation AFR AF = 0.00207 (86/41576). AF 95% confidence interval is 0.00172. There are 0 homozygotes in GnomAd4. There are 44 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 101 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.2368G>A | p.Val790Met | missense_variant | Exon 10 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.2368G>A | p.Val790Met | missense_variant | Exon 10 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.2368G>A | p.Val790Met | missense_variant | Exon 10 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.2368G>A | p.Val790Met | missense_variant | Exon 10 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.2368G>A | p.Val790Met | missense_variant | Exon 10 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.2368G>A | p.Val790Met | missense_variant | Exon 10 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.2329G>A | p.Val777Met | missense_variant | Exon 10 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.2368G>A | p.Val790Met | missense_variant | Exon 10 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.2329G>A | p.Val777Met | missense_variant | Exon 10 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000711482.1 | c.2368G>A | p.Val790Met | missense_variant | Exon 10 of 36 | ENSP00000518771.1 | ||||
CACNA1H | ENST00000711485.1 | c.2368G>A | p.Val790Met | missense_variant | Exon 10 of 35 | ENSP00000518774.1 | ||||
CACNA1H | ENST00000711455.1 | c.2368G>A | p.Val790Met | missense_variant | Exon 10 of 36 | ENSP00000518768.1 | ||||
CACNA1H | ENST00000711483.1 | c.2368G>A | p.Val790Met | missense_variant | Exon 10 of 35 | ENSP00000518772.1 | ||||
CACNA1H | ENST00000711456.1 | c.2368G>A | p.Val790Met | missense_variant | Exon 10 of 34 | ENSP00000518769.1 | ||||
CACNA1H | ENST00000621827.2 | n.2368G>A | non_coding_transcript_exon_variant | Exon 10 of 37 | 6 | ENSP00000518766.1 | ||||
CACNA1H | ENST00000637236.3 | n.2368G>A | non_coding_transcript_exon_variant | Exon 10 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.2368G>A | non_coding_transcript_exon_variant | Exon 10 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*281G>A | non_coding_transcript_exon_variant | Exon 10 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*1815G>A | non_coding_transcript_exon_variant | Exon 9 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.2368G>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.2368G>A | non_coding_transcript_exon_variant | Exon 10 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.2368G>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.2368G>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.2368G>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.2368G>A | non_coding_transcript_exon_variant | Exon 10 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.2368G>A | non_coding_transcript_exon_variant | Exon 10 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.2368G>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.2368G>A | non_coding_transcript_exon_variant | Exon 10 of 35 | ENSP00000518777.1 | |||||
CACNA1H | ENST00000640028.1 | n.*281G>A | 3_prime_UTR_variant | Exon 10 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*1815G>A | 3_prime_UTR_variant | Exon 9 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.000663 AC: 101AN: 152226Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
101
AN:
152226
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000211 AC: 44AN: 208906 AF XY: 0.000125 show subpopulations
GnomAD2 exomes
AF:
AC:
44
AN:
208906
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000749 AC: 106AN: 1415018Hom.: 0 Cov.: 32 AF XY: 0.0000630 AC XY: 44AN XY: 698808 show subpopulations
GnomAD4 exome
AF:
AC:
106
AN:
1415018
Hom.:
Cov.:
32
AF XY:
AC XY:
44
AN XY:
698808
show subpopulations
African (AFR)
AF:
AC:
62
AN:
32476
American (AMR)
AF:
AC:
15
AN:
39336
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
22684
East Asian (EAS)
AF:
AC:
0
AN:
39294
South Asian (SAS)
AF:
AC:
1
AN:
77448
European-Finnish (FIN)
AF:
AC:
0
AN:
49922
Middle Eastern (MID)
AF:
AC:
0
AN:
5542
European-Non Finnish (NFE)
AF:
AC:
13
AN:
1089988
Other (OTH)
AF:
AC:
15
AN:
58328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000663 AC: 101AN: 152344Hom.: 0 Cov.: 33 AF XY: 0.000591 AC XY: 44AN XY: 74498 show subpopulations
GnomAD4 genome
AF:
AC:
101
AN:
152344
Hom.:
Cov.:
33
AF XY:
AC XY:
44
AN XY:
74498
show subpopulations
African (AFR)
AF:
AC:
86
AN:
41576
American (AMR)
AF:
AC:
6
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
68030
Other (OTH)
AF:
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
9
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
33
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Sep 28, 2017
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D;.
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;.;M;M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;.;D;D
Sift4G
Pathogenic
D;.;D;D
Polyphen
D;.;D;D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.